|
?:authorAffiliation
|
-
[\'Department of Medicine, Division of Hematology & Oncology, Vanderbilt University Medical Center, Nashville, TN, USA.\', \'Department of Research, Evaluative Epidemiology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.\', \'Laboratory of Clinical Research, Methodology Oncology Department \'Mario Negri\' Institute of Pharmacological Researches, IRCCS, Milan, Italy.\', \'Thoracic Oncology Unit, Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.\', \'Department of Biotechnology and Applied Clinical Science, University of L\'Aquila, L\'Aquila, Italy.\', \'Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland.\', \'Gustave Roussy Cancer Center, Villejuif, France; Aix Marseille University, CNRS, INSERM, CRCM, Marseille, France.\', \'Department of Pulmonology, Erasmus University Medical Center, Rotterdam, University Maastricht, Maastricht, the Netherlands.\', \'Department of Pulmonology and Thoracic Oncology, Antwerp University Hospital, Edegem, Belgium.\', \'Univeristy Paul Sabatier, Toulouse, Inserm, Centre de Recherche en Cancérologie de Toulouse, Toulouse, France, Barcelona Supercomputing Center, Barcelona.\', \'National University Cancer Institute, Singapore.\', \'Princess Margaret Cancer Centre, Toronto, Canada.\', \'Department of Medicine, Division of Oncology, Stanford Cancer Institute, Stanford University, Stanford, CA, USA.\', \'Thoracic Oncology Unit, Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. Electronic address: marina.garassino@istitutotumori.mi.it.\', \'Department of Medicine, Division of Hematology & Oncology, Vanderbilt University Medical Center, Nashville, TN, USA; Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN, USA. Electronic address: leora.horn@vumc.org.\']
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}